[Featured Stock] Genome Analysis Technology Platform Company Selemix Hits Upper Limit
Genome analysis technology platform company Selemix is hitting the upper price limit.
As of 9:06 AM on the 12th, Selemix is trading at 5,200 KRW on the KOSDAQ market, up 1,200 KRW (30%) from the previous trading day.
![[Featured Stock] Genome Analysis Technology Platform Company Selemix Hits Upper Limit](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
Selemix has developed the next-generation cloning technology MSSIC and three productization technologies, conducting businesses in Target Capture kits, immune repertoire analysis solutions, and next-generation sequencing solutions.
It supplies products to major institutions in the bio industry such as hospitals, contract testing organizations, pharmaceutical companies, seed companies, and research institutes.
Hot Picks Today
![[Exclusive] "This Is Why Samsung Stands Out"... Onnuri Gift Certificates Replace Loyalty Points](https://cwcontent.asiae.co.kr/asiaresize/93/2026060511022289079_1780624942.jpg)
[Exclusive] "This Is Why Samsung Stands Out"... Onnuri Gift Certificates Replace Loyalty Points
- "Seoul's Nightlife Transformed: Why Fewer People Ride the Subway After Midnight"
- Drunk Man in His 30s Drives 1.5 km Dragging Substitute Driver to Death... Bereaved Family: "No Apology"
- "What Would Those Ignorant People Know? They Won't Notice If We Don't Give Them Ballots"…Drama Scene Resurfaces Amid Ballot Shortage Crisis
- 'Youngest' Koo Kwangmo Fills Water Glasses, 'Eldest' Chey Taewon Pours Drinks... Toast: "Go Korea! SK, LG, Naver"
It is used as an essential material to create value in a wide range of fields including diagnostics, new drug development, seed development, synthetic biology, microbiome, and academic research.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
